Showing 611-620 of 9351 results for "".
Time Is Hair: An Update on the Diagnosis and Treatment of Scarring Alopecias in Patients with Darker Skin Tones
https://practicaldermatology.com/programs/practical-dermatology/time-is-hair-an-update-on-the-diagnosis-and-treatment-of-scarring-alopecia-in-patients-with-darker-skin-tones/18198/In part two of a three-part podcast series on dermatologic issues facing patients with darker skin tones, Dr. Andrew Alexis, a dermatologist from New York City and the President of the Skin of Color Society; Dr. Corey Hartman, a dermatologist in Birmingham, Alabama; and Dr. Janiene Luke, a dermatoloAdvancing Digital Medicine in Dermatology
https://practicaldermatology.com/programs/practical-dermatology/advancing-digital-medicine-in-dermatology/18187/The Digital Medicine Society (DiME) is a global nonprofit dedicated to advancing the ethical, effective, equitable, and safe use of digital medicine to redefine health care and improve lives. DiME recently released a new set of resources, available at www.dimesociety.org/access-resources/, to advancNew FDA Approval for AD
https://practicaldermatology.com/series/c-suite-chats/new-fda-approval-for-ad/29911/Phil Brown, MD, JD, Dermatologic Scientific Lead at Organon, talks about the importance of a new FDA-approved topical solution for treating atopic dermatitis.DermWireTV: Atopic Dermatitis Pipeline Watch, a Potential New Skin Cancer Treatment; Demystifying Itch, and the Premiere of PA Perspectives
https://practicaldermatology.com/topics/practice-management/dermwiretv-atopic-dermatitis-pipeline-watch-a-potential-new-skin-cancer-treatment-demystifying-itch-and-the-premiere-of-pa-perspectives/20228/Escient Pharmaceuticals, Rapt Therapeutics, and Connect Biopharma each report positive results from early clinical studies in AD. Finnish researchers discover a potential treatment for cutaneous squamous cell carcinoma in an existing chemotherapy drug. Research out of Harvard Medical School links ecWeighing the Role of Network Meta-analysis for Choosing Biologic Therapies in Psoriatic Disease
https://practicaldermatology.com/programs/practical-dermatology/weighing-the-role-of-network-meta-analysis-for-choosing-biologic-therapies-in-psoriatic-disease/18189/There’s no paucity of studies for biologic therapies used to treat psoriatic disease, but the number of head-to-head trials comparing these agents is limited. Enter network meta-analysis, a statistical methodology that has emerged over the past few years to compare medication. Philip Mease, MD, a clRed Light vs Blue Light Therapy
https://practicaldermatology.com/series/pdt-in-practice/red-light-vs-blue-light-therapy/26993/Dr. Hamza D. Bhatti, a board-certified dermatologist and dually accredited fellowship-trained Mohs micrographic surgeon and cosmetic dermatologic surgeon, discusses the differences between red light and blue light photodynamic therapy (PDT), the advantages of each, and some off-label uses of PDT.DermWireTV: Diversity in Dermatology; Inclusive Beauty Initiatives; Eczema Awareness Month
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-diversity-in-dermatology-inclusive-beauty-initiatives-eczema-awareness-month/20152/La Roche-Posay and the Women's Dermatologic Society have partnered to sponsor a Fellowship in the Department of Dermatology at Howard University's College of Medicine for Underrepresented in medicine medical students. WDS President Mona Gohara, MD shares insights about the need to support DEI in der"Best Practices in the Treatment of Acne" Drs. Harper and Stein-Gold
https://practicaldermatology.com/youngmd-connect/ymdc-workshops/best-practices-in-the-treatment-of-acne-drs-harper-and-stein-gold/24543/Expert dermatologists Drs. Linda Stein Gold and Julie Harper share their insights on treating acne across all severities. Join their discussion with YoungMD Connect members for valuable experiences and practice pearls. To access the full video and more, become a YoungMD Connect member for free 90-daDupixent Approved for Spontaneous Urticaria
https://practicaldermatology.com/series/dermwire-tv/dupixent-approved-for-spontaneous-urticaria/35635/In this week's DermwireTV, the FDA approves the first new therapy for spontaneous urticaria in more than 10 years; a new study examines investigational oral Icotrokinra in adolescents with plaque psoriasis; and Practical Dermatology launches a new series addressing trends and innovations in the treaSDPA: Dr. Audrey Rutherford Shares How Vulvovaginal Dermatology Became Her Specialty
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-dr-audrey-rutherford-shares-how-vulvovaginal-dermatology-became-her-specialty/29511/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with Audrey Rutherford, MD. Dr. Rutherford shares how she got started in vulvovaginal dermatology and key takeaways from her lecture.